Speciality Medicines was originally incorporated as ‘Speciality Medicines Private Limited’ as a Private Limited Company on February 05, 2021. Later on, pursuant to a special resolution passed by its shareholders in the extra-ordinary general meeting held on April 04, 2024, the company was converted from a private limited company to public limited company and consequently, the name of the company was changed from ‘Speciality Medicines Private Limited’ to ‘Speciality Medicines Limited’ on June 25, 2024.

It is engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising of high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. It offers a diverse portfolio of specialty pharmaceutical products, focusing on various therapeutic areas such as oncology, immunology, neurology, and rare diseases. Its products which are offered in such areas are available in a wide range of dosage forms like Tablets, Capsules, Cream, Syrups, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet and Suspension. It operates through two integrated business models: (a) Manufacturing, through contract manufacturing basis, of approved finished formulations and distribution internationally and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers.

Under its contract manufacturing arrangement, its contract manufacturer based in India is responsible for the manufacturing of speciality pharmaceutical formulations. These formulations are either approved or currently undergoing the approval process with the relevant health authorities in the target countries. Once the necessary regulatory approvals are obtained, it initiates its role as the distributor for these products. Its responsibilities include overseeing the marketing and distribution of the approved specialty pharmaceutical products across multiple international markets. Under its other business model, it operates as a distributor of specialty pharmaceutical products sourced from manufacturers. Its role focuses on the procurement, warehousing, and wholesale distribution of these medicines to a wide network of healthcare providers and retailers. It ensures smooth supply chain operations and timely delivery across various regions. Its services are centred on maintaining consistent product availability and supporting its customers through reliable and efficient distribution.

Business area of the company

The company is primarily engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising of high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its products are supplied to both domestic and international markets.

Products categories of the company

• Anti-Cancer: Medicines for prevention, control, or treatment of different types of cancers including solid tumours and blood cancers. 
• Vaccines (Human & Veterinary): Preventive 155mmunization products to protect humans and animals from viral and bacterial diseases. 
• Critical Care: High-urgency medicines used in intensive care units for life-saving interventions and severe medical conditions. 
• Anti-Diabetic: Therapies to manage blood glucose levels in patients with Type 1 and Type 2 diabetes.
• Gynecology: Medicines for women’s reproductive health, hormonal balance, and pregnancy-related conditions. 
• Nephrology: Treatments for chronic kidney diseases, dialysis support, and electrolyte management.
• Dermatology: Medications for skin infections, inflammatory skin disorders, and dermatological maintenance.
• Anti-Hypertensive: Drugs to control high blood pressure and prevent related cardiovascular complications.
• Anti-Malarial: Medicines for the prevention and treatment of malaria caused by Plasmodium parasites.
• Antibiotics (Human & Veterinary): Broad- and narrow-spectrum drugs to treat bacterial infections in humans and animals.
• Antiviral Therapies: Targeted treatments for viral infections such as Hepatitis B, Hepatitis C, HIV, COVID19, and Influenza.
• Chronic & Autoimmune Disorders: Long-term disease management including thyroid disorders, arthritis, and autoimmune-related inflammation. 
• Ophthalmic Care: Treatments for eye conditions such as glaucoma, infections, and vision-related issues.
• Anti-TB: Multi-drug regimens for the treatment and eradication of tuberculosis. 
• Steroid Therapy: Anti-inflammatory and immunosuppressive medicines used in acute and chronic conditions.
• Anti-Fungal: Drugs to prevent or treat fungal infections affecting skin, nails, and internal organs.
• Ayurvedic & Herbal: Herbal formulations and alternative medicines for wellness and therapeutic support.
• Erectile Dysfunction: Medicines to improve male sexual function and address erectile disorders.
• Dental Products: Products for oral hygiene, dental infection control, and gum disease management.
• Vitamins & Supplements: Nutritional support products, including vitamin and mineral supplements, for overall health maintenance.
• Surgical Products: Supplies and consumables used in surgical procedures and hospital care.
• Symptom Relief: Medicines to reduce fever, pain, and other common discomforts.

History and milestones

• 2021: Incorporation of the company viz. ‘Speciality Medicines Private Limited’.
• 2021: The company shifted its operation to Mumbai, Maharashtra, India 
• 2022: The company was recognized as Start-up by Department for Promotion of Industry and Internal Trade 
• 2023: The company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.
• 2024: Conversion of the company from private limited to public limited company.